SKINQ, an Indian skincare brand led by dermatologists, announced in September 2026 that it will expand its sales channels from D2C-only to also selling through stores. Co-founder Ashish Mishra says the company will grow the business by combining direct online sales with offline retail, built around evidence-focused formulations for Indian and melanin-rich skin. This is a shift that revisits who sells, on what evidence, and through which channel — and it offers Japanese cosmetics companies material for reading how dermatology-driven skincare goes about scaling up.
What SKINQ has put forward is an omnichannel move that adds the touchpoint of physical stores on top of D2C, which had been its core so far. It will use social media for consumer education and relationship-building while expanding its customer base on both the online and offline fronts. Mishra said, "skincare should be guided by what the skin truly needs, not by market trends or excessive ingredients," describing the brand's principle as "proof over promise." This announcement does not disclose a specific number of stores, target cities, or price range.
What SKINQ targets are concerns such as pigmentation, sensitivity, inflammation, acne, skin-barrier repair, and UV damage. Standing on the premise that uniform global-standard formulations cannot fully address the concerns of Indian and melanin-rich skin, it puts forward formulations designed to fill that gap. By being dermatologist-led and putting measurable effects and scientific backing front and center, it has made clear a position of delivering only what the skin needs, rather than piling on ingredients. Concerns such as pigmentation and inflammation tend to be linked to India's intense sunlight and hot, humid climate, and whether a formulation has been validated for local skin becomes the deciding factor in what gets chosen.
Direct online sales let a company hold onto customer data and margin, but they easily miss the segment that wants to actually touch and try products on their skin before choosing. SKINQ is adding stores to create a touchpoint reaching this segment and to convey its dermatologist-founded credibility face to face. India's beauty D2C sector has seen a continuing trend of moving from early online-only operations to also selling in stores, and SKINQ is following that same common path. The more a brand emphasizes proof, the more a sales floor that can explain effects face to face pays off.
Mishra's messaging centers on explaining the brand's philosophy and channel policy, and no quantitative figures such as store count or sales are given this time. The pattern itself — a dermatologist-led brand holding up scientific backing as it expands from D2C into stores — is one repeatedly seen in India's beauty market. The question now is whether an approach that avoids exaggeration and centers on proof will reach consumers who are tired of ingredient one-upmanship.
When Japanese skincare players enter India, SKINQ's model raises the question of "how, and through which channel, to convey the trust that comes from expertise." Dermatologist supervision and clinical backing are hard to convey through online copy alone, and in-store service and experience carry more weight. The case of SK-II entering through Nykaa stores plus AI skin diagnostics and Kose's investment in a local D2C brand shows one path for conveying expertise through face-to-face contact or a local D2C brand. The realistic approach is to first determine whether your own strength is "proof" type or "buzz" type, and enter through the channel that fits.
SKINQ's move into stores is not an isolated case. The move by Mamaearth's parent company to bring in a dermatologist network and expand into the health market— as this shows, India's beauty and health brands are following a path of letting the customer base they built online spill over into stores and new areas.
SKINQ, built around the expertise of being dermatologist-founded, is looking to expand from D2C-only into also selling through stores. If Japanese skincare players want to test this market, rather than competing on the number of ingredients or buzz, it pays to first secure one sales floor where you can convey "proof" — clinical backing or supervision — face to face, and then expand horizontally online along whichever concern axis got through there. The place to start is putting one piece of your own evidence of efficacy into a form you can tell in store.
RECENT
2026.09.24Bridgestone India’s 30th-anniversary film builds on the founder’s motto2026.09.24Flipkart’s move: putting the two meanings of "BBD" on Kolkata buses2026.09.24Veteran fertilizer maker KICL enters beverages with coconut water, starting in three South Indian states2026.09.24Pinit delivers saris in under 45 minutes, setting up a mirror and lighting at the customer’s home to choose fromCONTACT
Considering entering the Indian market?
Building on the developments on the ground covered in this article, we will suggest an approach that fits your products.
Book a free consultation →SOJAPAN
We support Japanese companies entering India, from market research through local partner development, test sales, and import.